Global Plasma Derived Medicine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Plasma Derived Medicine market size was valued at US$ 2241.2 million in 2023. With growing demand in downstream market, the Plasma Derived Medicine is forecast to a readjusted size of US$ 3863.9 million by 2030 with a CAGR of 8.1% during review period.
The research report highlights the growth potential of the global Plasma Derived Medicine market. Plasma Derived Medicine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Plasma Derived Medicine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Plasma Derived Medicine market.
Plasma Derived Medicine is any therapeutic substance prepared from human blood.
Key Features:
The report on Plasma Derived Medicine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Plasma Derived Medicine market. It may include historical data, market segmentation by Type (e.g., Albumin, Immune Globulin), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Plasma Derived Medicine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Plasma Derived Medicine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Plasma Derived Medicine industry. This include advancements in Plasma Derived Medicine technology, Plasma Derived Medicine new entrants, Plasma Derived Medicine new investment, and other innovations that are shaping the future of Plasma Derived Medicine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Plasma Derived Medicine market. It includes factors influencing customer ' purchasing decisions, preferences for Plasma Derived Medicine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Plasma Derived Medicine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Plasma Derived Medicine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Plasma Derived Medicine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Plasma Derived Medicine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Plasma Derived Medicine market.
Market Segmentation:
Plasma Derived Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Plasma Derived Medicine market?
What factors are driving Plasma Derived Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Plasma Derived Medicine market opportunities vary by end market size?
How does Plasma Derived Medicine break out type, application?
According to our LPI (LP Information) latest study, the global Plasma Derived Medicine market size was valued at US$ 2241.2 million in 2023. With growing demand in downstream market, the Plasma Derived Medicine is forecast to a readjusted size of US$ 3863.9 million by 2030 with a CAGR of 8.1% during review period.
The research report highlights the growth potential of the global Plasma Derived Medicine market. Plasma Derived Medicine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Plasma Derived Medicine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Plasma Derived Medicine market.
Plasma Derived Medicine is any therapeutic substance prepared from human blood.
Key Features:
The report on Plasma Derived Medicine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Plasma Derived Medicine market. It may include historical data, market segmentation by Type (e.g., Albumin, Immune Globulin), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Plasma Derived Medicine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Plasma Derived Medicine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Plasma Derived Medicine industry. This include advancements in Plasma Derived Medicine technology, Plasma Derived Medicine new entrants, Plasma Derived Medicine new investment, and other innovations that are shaping the future of Plasma Derived Medicine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Plasma Derived Medicine market. It includes factors influencing customer ' purchasing decisions, preferences for Plasma Derived Medicine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Plasma Derived Medicine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Plasma Derived Medicine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Plasma Derived Medicine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Plasma Derived Medicine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Plasma Derived Medicine market.
Market Segmentation:
Plasma Derived Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Albumin
- Immune Globulin
- Coagulation Factor
- Others
- Bleeding Wound
- Immunodeficiency
- HBV
- Tetanus
- Rabies
- Hemophilia
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- Shanghai RAAS
- China Biologic Products
- Hualan Biological Engineering Inc.
- Beijing Tiantan Biological Products Corp
- Pacific Shuanglin
- Boya Bio-Pharmaceutical
- Paisi Feike Biology Pharmacy Co., Ltd.
- Xinjiang Deyuan Bioengineering
- Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
- Shenzhen Weiguang
- Shanxi Kangbao
- Nanyue Biopharming Corporation Ltd
What is the 10-year outlook for the global Plasma Derived Medicine market?
What factors are driving Plasma Derived Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Plasma Derived Medicine market opportunities vary by end market size?
How does Plasma Derived Medicine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Plasma Derived Medicine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Plasma Derived Medicine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Plasma Derived Medicine by Country/Region, 2019, 2023 & 2030
2.2 Plasma Derived Medicine Segment by Type
2.2.1 Albumin
2.2.2 Immune Globulin
2.2.3 Coagulation Factor
2.2.4 Others
2.3 Plasma Derived Medicine Sales by Type
2.3.1 Global Plasma Derived Medicine Sales Market Share by Type (2019-2024)
2.3.2 Global Plasma Derived Medicine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Plasma Derived Medicine Sale Price by Type (2019-2024)
2.4 Plasma Derived Medicine Segment by Application
2.4.1 Bleeding Wound
2.4.2 Immunodeficiency
2.4.3 HBV
2.4.4 Tetanus
2.4.5 Rabies
2.4.6 Hemophilia
2.4.7 Others
2.5 Plasma Derived Medicine Sales by Application
2.5.1 Global Plasma Derived Medicine Sale Market Share by Application (2019-2024)
2.5.2 Global Plasma Derived Medicine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Plasma Derived Medicine Sale Price by Application (2019-2024)
3 GLOBAL PLASMA DERIVED MEDICINE BY COMPANY
3.1 Global Plasma Derived Medicine Breakdown Data by Company
3.1.1 Global Plasma Derived Medicine Annual Sales by Company (2019-2024)
3.1.2 Global Plasma Derived Medicine Sales Market Share by Company (2019-2024)
3.2 Global Plasma Derived Medicine Annual Revenue by Company (2019-2024)
3.2.1 Global Plasma Derived Medicine Revenue by Company (2019-2024)
3.2.2 Global Plasma Derived Medicine Revenue Market Share by Company (2019-2024)
3.3 Global Plasma Derived Medicine Sale Price by Company
3.4 Key Manufacturers Plasma Derived Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plasma Derived Medicine Product Location Distribution
3.4.2 Players Plasma Derived Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PLASMA DERIVED MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Plasma Derived Medicine Market Size by Geographic Region (2019-2024)
4.1.1 Global Plasma Derived Medicine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Plasma Derived Medicine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Plasma Derived Medicine Market Size by Country/Region (2019-2024)
4.2.1 Global Plasma Derived Medicine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Plasma Derived Medicine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Plasma Derived Medicine Sales Growth
4.4 APAC Plasma Derived Medicine Sales Growth
4.5 Europe Plasma Derived Medicine Sales Growth
4.6 Middle East & Africa Plasma Derived Medicine Sales Growth
5 AMERICAS
5.1 Americas Plasma Derived Medicine Sales by Country
5.1.1 Americas Plasma Derived Medicine Sales by Country (2019-2024)
5.1.2 Americas Plasma Derived Medicine Revenue by Country (2019-2024)
5.2 Americas Plasma Derived Medicine Sales by Type
5.3 Americas Plasma Derived Medicine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasma Derived Medicine Sales by Region
6.1.1 APAC Plasma Derived Medicine Sales by Region (2019-2024)
6.1.2 APAC Plasma Derived Medicine Revenue by Region (2019-2024)
6.2 APAC Plasma Derived Medicine Sales by Type
6.3 APAC Plasma Derived Medicine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Plasma Derived Medicine by Country
7.1.1 Europe Plasma Derived Medicine Sales by Country (2019-2024)
7.1.2 Europe Plasma Derived Medicine Revenue by Country (2019-2024)
7.2 Europe Plasma Derived Medicine Sales by Type
7.3 Europe Plasma Derived Medicine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Plasma Derived Medicine by Country
8.1.1 Middle East & Africa Plasma Derived Medicine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Plasma Derived Medicine Revenue by Country (2019-2024)
8.2 Middle East & Africa Plasma Derived Medicine Sales by Type
8.3 Middle East & Africa Plasma Derived Medicine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Plasma Derived Medicine
10.3 Manufacturing Process Analysis of Plasma Derived Medicine
10.4 Industry Chain Structure of Plasma Derived Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Plasma Derived Medicine Distributors
11.3 Plasma Derived Medicine Customer
12 WORLD FORECAST REVIEW FOR PLASMA DERIVED MEDICINE BY GEOGRAPHIC REGION
12.1 Global Plasma Derived Medicine Market Size Forecast by Region
12.1.1 Global Plasma Derived Medicine Forecast by Region (2025-2030)
12.1.2 Global Plasma Derived Medicine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Plasma Derived Medicine Forecast by Type
12.7 Global Plasma Derived Medicine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Plasma Derived Medicine Product Portfolios and Specifications
13.1.3 Takeda Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Plasma Derived Medicine Product Portfolios and Specifications
13.2.3 CSL Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Plasma Derived Medicine Product Portfolios and Specifications
13.3.3 Grifols Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Plasma Derived Medicine Product Portfolios and Specifications
13.4.3 Octapharma Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Kedrion
13.5.1 Kedrion Company Information
13.5.2 Kedrion Plasma Derived Medicine Product Portfolios and Specifications
13.5.3 Kedrion Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Kedrion Main Business Overview
13.5.5 Kedrion Latest Developments
13.6 LFB Group
13.6.1 LFB Group Company Information
13.6.2 LFB Group Plasma Derived Medicine Product Portfolios and Specifications
13.6.3 LFB Group Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 LFB Group Main Business Overview
13.6.5 LFB Group Latest Developments
13.7 Biotest
13.7.1 Biotest Company Information
13.7.2 Biotest Plasma Derived Medicine Product Portfolios and Specifications
13.7.3 Biotest Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Biotest Main Business Overview
13.7.5 Biotest Latest Developments
13.8 BPL
13.8.1 BPL Company Information
13.8.2 BPL Plasma Derived Medicine Product Portfolios and Specifications
13.8.3 BPL Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 BPL Main Business Overview
13.8.5 BPL Latest Developments
13.9 Shanghai RAAS
13.9.1 Shanghai RAAS Company Information
13.9.2 Shanghai RAAS Plasma Derived Medicine Product Portfolios and Specifications
13.9.3 Shanghai RAAS Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Shanghai RAAS Main Business Overview
13.9.5 Shanghai RAAS Latest Developments
13.10 China Biologic Products
13.10.1 China Biologic Products Company Information
13.10.2 China Biologic Products Plasma Derived Medicine Product Portfolios and Specifications
13.10.3 China Biologic Products Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 China Biologic Products Main Business Overview
13.10.5 China Biologic Products Latest Developments
13.11 Hualan Biological Engineering Inc.
13.11.1 Hualan Biological Engineering Inc. Company Information
13.11.2 Hualan Biological Engineering Inc. Plasma Derived Medicine Product Portfolios and Specifications
13.11.3 Hualan Biological Engineering Inc. Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hualan Biological Engineering Inc. Main Business Overview
13.11.5 Hualan Biological Engineering Inc. Latest Developments
13.12 Beijing Tiantan Biological Products Corp
13.12.1 Beijing Tiantan Biological Products Corp Company Information
13.12.2 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Portfolios and Specifications
13.12.3 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Beijing Tiantan Biological Products Corp Main Business Overview
13.12.5 Beijing Tiantan Biological Products Corp Latest Developments
13.13 Pacific Shuanglin
13.13.1 Pacific Shuanglin Company Information
13.13.2 Pacific Shuanglin Plasma Derived Medicine Product Portfolios and Specifications
13.13.3 Pacific Shuanglin Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Pacific Shuanglin Main Business Overview
13.13.5 Pacific Shuanglin Latest Developments
13.14 Boya Bio-Pharmaceutical
13.14.1 Boya Bio-Pharmaceutical Company Information
13.14.2 Boya Bio-Pharmaceutical Plasma Derived Medicine Product Portfolios and Specifications
13.14.3 Boya Bio-Pharmaceutical Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Boya Bio-Pharmaceutical Main Business Overview
13.14.5 Boya Bio-Pharmaceutical Latest Developments
13.15 Paisi Feike Biology Pharmacy Co., Ltd.
13.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Company Information
13.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Portfolios and Specifications
13.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Main Business Overview
13.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Latest Developments
13.16 Xinjiang Deyuan Bioengineering
13.16.1 Xinjiang Deyuan Bioengineering Company Information
13.16.2 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Portfolios and Specifications
13.16.3 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Xinjiang Deyuan Bioengineering Main Business Overview
13.16.5 Xinjiang Deyuan Bioengineering Latest Developments
13.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
13.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information
13.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Portfolios and Specifications
13.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Main Business Overview
13.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Latest Developments
13.18 Shenzhen Weiguang
13.18.1 Shenzhen Weiguang Company Information
13.18.2 Shenzhen Weiguang Plasma Derived Medicine Product Portfolios and Specifications
13.18.3 Shenzhen Weiguang Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Shenzhen Weiguang Main Business Overview
13.18.5 Shenzhen Weiguang Latest Developments
13.19 Shanxi Kangbao
13.19.1 Shanxi Kangbao Company Information
13.19.2 Shanxi Kangbao Plasma Derived Medicine Product Portfolios and Specifications
13.19.3 Shanxi Kangbao Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Shanxi Kangbao Main Business Overview
13.19.5 Shanxi Kangbao Latest Developments
13.20 Nanyue Biopharming Corporation Ltd
13.20.1 Nanyue Biopharming Corporation Ltd Company Information
13.20.2 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Portfolios and Specifications
13.20.3 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Nanyue Biopharming Corporation Ltd Main Business Overview
13.20.5 Nanyue Biopharming Corporation Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Plasma Derived Medicine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Plasma Derived Medicine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Plasma Derived Medicine by Country/Region, 2019, 2023 & 2030
2.2 Plasma Derived Medicine Segment by Type
2.2.1 Albumin
2.2.2 Immune Globulin
2.2.3 Coagulation Factor
2.2.4 Others
2.3 Plasma Derived Medicine Sales by Type
2.3.1 Global Plasma Derived Medicine Sales Market Share by Type (2019-2024)
2.3.2 Global Plasma Derived Medicine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Plasma Derived Medicine Sale Price by Type (2019-2024)
2.4 Plasma Derived Medicine Segment by Application
2.4.1 Bleeding Wound
2.4.2 Immunodeficiency
2.4.3 HBV
2.4.4 Tetanus
2.4.5 Rabies
2.4.6 Hemophilia
2.4.7 Others
2.5 Plasma Derived Medicine Sales by Application
2.5.1 Global Plasma Derived Medicine Sale Market Share by Application (2019-2024)
2.5.2 Global Plasma Derived Medicine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Plasma Derived Medicine Sale Price by Application (2019-2024)
3 GLOBAL PLASMA DERIVED MEDICINE BY COMPANY
3.1 Global Plasma Derived Medicine Breakdown Data by Company
3.1.1 Global Plasma Derived Medicine Annual Sales by Company (2019-2024)
3.1.2 Global Plasma Derived Medicine Sales Market Share by Company (2019-2024)
3.2 Global Plasma Derived Medicine Annual Revenue by Company (2019-2024)
3.2.1 Global Plasma Derived Medicine Revenue by Company (2019-2024)
3.2.2 Global Plasma Derived Medicine Revenue Market Share by Company (2019-2024)
3.3 Global Plasma Derived Medicine Sale Price by Company
3.4 Key Manufacturers Plasma Derived Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plasma Derived Medicine Product Location Distribution
3.4.2 Players Plasma Derived Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PLASMA DERIVED MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Plasma Derived Medicine Market Size by Geographic Region (2019-2024)
4.1.1 Global Plasma Derived Medicine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Plasma Derived Medicine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Plasma Derived Medicine Market Size by Country/Region (2019-2024)
4.2.1 Global Plasma Derived Medicine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Plasma Derived Medicine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Plasma Derived Medicine Sales Growth
4.4 APAC Plasma Derived Medicine Sales Growth
4.5 Europe Plasma Derived Medicine Sales Growth
4.6 Middle East & Africa Plasma Derived Medicine Sales Growth
5 AMERICAS
5.1 Americas Plasma Derived Medicine Sales by Country
5.1.1 Americas Plasma Derived Medicine Sales by Country (2019-2024)
5.1.2 Americas Plasma Derived Medicine Revenue by Country (2019-2024)
5.2 Americas Plasma Derived Medicine Sales by Type
5.3 Americas Plasma Derived Medicine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasma Derived Medicine Sales by Region
6.1.1 APAC Plasma Derived Medicine Sales by Region (2019-2024)
6.1.2 APAC Plasma Derived Medicine Revenue by Region (2019-2024)
6.2 APAC Plasma Derived Medicine Sales by Type
6.3 APAC Plasma Derived Medicine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Plasma Derived Medicine by Country
7.1.1 Europe Plasma Derived Medicine Sales by Country (2019-2024)
7.1.2 Europe Plasma Derived Medicine Revenue by Country (2019-2024)
7.2 Europe Plasma Derived Medicine Sales by Type
7.3 Europe Plasma Derived Medicine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Plasma Derived Medicine by Country
8.1.1 Middle East & Africa Plasma Derived Medicine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Plasma Derived Medicine Revenue by Country (2019-2024)
8.2 Middle East & Africa Plasma Derived Medicine Sales by Type
8.3 Middle East & Africa Plasma Derived Medicine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Plasma Derived Medicine
10.3 Manufacturing Process Analysis of Plasma Derived Medicine
10.4 Industry Chain Structure of Plasma Derived Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Plasma Derived Medicine Distributors
11.3 Plasma Derived Medicine Customer
12 WORLD FORECAST REVIEW FOR PLASMA DERIVED MEDICINE BY GEOGRAPHIC REGION
12.1 Global Plasma Derived Medicine Market Size Forecast by Region
12.1.1 Global Plasma Derived Medicine Forecast by Region (2025-2030)
12.1.2 Global Plasma Derived Medicine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Plasma Derived Medicine Forecast by Type
12.7 Global Plasma Derived Medicine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Plasma Derived Medicine Product Portfolios and Specifications
13.1.3 Takeda Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Plasma Derived Medicine Product Portfolios and Specifications
13.2.3 CSL Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Plasma Derived Medicine Product Portfolios and Specifications
13.3.3 Grifols Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Plasma Derived Medicine Product Portfolios and Specifications
13.4.3 Octapharma Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Kedrion
13.5.1 Kedrion Company Information
13.5.2 Kedrion Plasma Derived Medicine Product Portfolios and Specifications
13.5.3 Kedrion Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Kedrion Main Business Overview
13.5.5 Kedrion Latest Developments
13.6 LFB Group
13.6.1 LFB Group Company Information
13.6.2 LFB Group Plasma Derived Medicine Product Portfolios and Specifications
13.6.3 LFB Group Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 LFB Group Main Business Overview
13.6.5 LFB Group Latest Developments
13.7 Biotest
13.7.1 Biotest Company Information
13.7.2 Biotest Plasma Derived Medicine Product Portfolios and Specifications
13.7.3 Biotest Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Biotest Main Business Overview
13.7.5 Biotest Latest Developments
13.8 BPL
13.8.1 BPL Company Information
13.8.2 BPL Plasma Derived Medicine Product Portfolios and Specifications
13.8.3 BPL Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 BPL Main Business Overview
13.8.5 BPL Latest Developments
13.9 Shanghai RAAS
13.9.1 Shanghai RAAS Company Information
13.9.2 Shanghai RAAS Plasma Derived Medicine Product Portfolios and Specifications
13.9.3 Shanghai RAAS Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Shanghai RAAS Main Business Overview
13.9.5 Shanghai RAAS Latest Developments
13.10 China Biologic Products
13.10.1 China Biologic Products Company Information
13.10.2 China Biologic Products Plasma Derived Medicine Product Portfolios and Specifications
13.10.3 China Biologic Products Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 China Biologic Products Main Business Overview
13.10.5 China Biologic Products Latest Developments
13.11 Hualan Biological Engineering Inc.
13.11.1 Hualan Biological Engineering Inc. Company Information
13.11.2 Hualan Biological Engineering Inc. Plasma Derived Medicine Product Portfolios and Specifications
13.11.3 Hualan Biological Engineering Inc. Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hualan Biological Engineering Inc. Main Business Overview
13.11.5 Hualan Biological Engineering Inc. Latest Developments
13.12 Beijing Tiantan Biological Products Corp
13.12.1 Beijing Tiantan Biological Products Corp Company Information
13.12.2 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Portfolios and Specifications
13.12.3 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Beijing Tiantan Biological Products Corp Main Business Overview
13.12.5 Beijing Tiantan Biological Products Corp Latest Developments
13.13 Pacific Shuanglin
13.13.1 Pacific Shuanglin Company Information
13.13.2 Pacific Shuanglin Plasma Derived Medicine Product Portfolios and Specifications
13.13.3 Pacific Shuanglin Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Pacific Shuanglin Main Business Overview
13.13.5 Pacific Shuanglin Latest Developments
13.14 Boya Bio-Pharmaceutical
13.14.1 Boya Bio-Pharmaceutical Company Information
13.14.2 Boya Bio-Pharmaceutical Plasma Derived Medicine Product Portfolios and Specifications
13.14.3 Boya Bio-Pharmaceutical Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Boya Bio-Pharmaceutical Main Business Overview
13.14.5 Boya Bio-Pharmaceutical Latest Developments
13.15 Paisi Feike Biology Pharmacy Co., Ltd.
13.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Company Information
13.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Portfolios and Specifications
13.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Main Business Overview
13.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Latest Developments
13.16 Xinjiang Deyuan Bioengineering
13.16.1 Xinjiang Deyuan Bioengineering Company Information
13.16.2 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Portfolios and Specifications
13.16.3 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Xinjiang Deyuan Bioengineering Main Business Overview
13.16.5 Xinjiang Deyuan Bioengineering Latest Developments
13.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
13.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information
13.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Portfolios and Specifications
13.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Main Business Overview
13.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Latest Developments
13.18 Shenzhen Weiguang
13.18.1 Shenzhen Weiguang Company Information
13.18.2 Shenzhen Weiguang Plasma Derived Medicine Product Portfolios and Specifications
13.18.3 Shenzhen Weiguang Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Shenzhen Weiguang Main Business Overview
13.18.5 Shenzhen Weiguang Latest Developments
13.19 Shanxi Kangbao
13.19.1 Shanxi Kangbao Company Information
13.19.2 Shanxi Kangbao Plasma Derived Medicine Product Portfolios and Specifications
13.19.3 Shanxi Kangbao Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Shanxi Kangbao Main Business Overview
13.19.5 Shanxi Kangbao Latest Developments
13.20 Nanyue Biopharming Corporation Ltd
13.20.1 Nanyue Biopharming Corporation Ltd Company Information
13.20.2 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Portfolios and Specifications
13.20.3 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Nanyue Biopharming Corporation Ltd Main Business Overview
13.20.5 Nanyue Biopharming Corporation Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Plasma Derived Medicine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Plasma Derived Medicine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Albumin
Table 4. Major Players of Immune Globulin
Table 5. Major Players of Coagulation Factor
Table 6. Major Players of Others
Table 7. Global Plasma Derived Medicine Sales by Type (2019-2024) & (K Bottles)
Table 8. Global Plasma Derived Medicine Sales Market Share by Type (2019-2024)
Table 9. Global Plasma Derived Medicine Revenue by Type (2019-2024) & ($ million)
Table 10. Global Plasma Derived Medicine Revenue Market Share by Type (2019-2024)
Table 11. Global Plasma Derived Medicine Sale Price by Type (2019-2024) & (USD/Bottle)
Table 12. Global Plasma Derived Medicine Sales by Application (2019-2024) & (K Bottles)
Table 13. Global Plasma Derived Medicine Sales Market Share by Application (2019-2024)
Table 14. Global Plasma Derived Medicine Revenue by Application (2019-2024)
Table 15. Global Plasma Derived Medicine Revenue Market Share by Application (2019-2024)
Table 16. Global Plasma Derived Medicine Sale Price by Application (2019-2024) & (USD/Bottle)
Table 17. Global Plasma Derived Medicine Sales by Company (2019-2024) & (K Bottles)
Table 18. Global Plasma Derived Medicine Sales Market Share by Company (2019-2024)
Table 19. Global Plasma Derived Medicine Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Plasma Derived Medicine Revenue Market Share by Company (2019-2024)
Table 21. Global Plasma Derived Medicine Sale Price by Company (2019-2024) & (USD/Bottle)
Table 22. Key Manufacturers Plasma Derived Medicine Producing Area Distribution and Sales Area
Table 23. Players Plasma Derived Medicine Products Offered
Table 24. Plasma Derived Medicine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Plasma Derived Medicine Sales by Geographic Region (2019-2024) & (K Bottles)
Table 28. Global Plasma Derived Medicine Sales Market Share Geographic Region (2019-2024)
Table 29. Global Plasma Derived Medicine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Plasma Derived Medicine Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Plasma Derived Medicine Sales by Country/Region (2019-2024) & (K Bottles)
Table 32. Global Plasma Derived Medicine Sales Market Share by Country/Region (2019-2024)
Table 33. Global Plasma Derived Medicine Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Plasma Derived Medicine Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Plasma Derived Medicine Sales by Country (2019-2024) & (K Bottles)
Table 36. Americas Plasma Derived Medicine Sales Market Share by Country (2019-2024)
Table 37. Americas Plasma Derived Medicine Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Plasma Derived Medicine Revenue Market Share by Country (2019-2024)
Table 39. Americas Plasma Derived Medicine Sales by Type (2019-2024) & (K Bottles)
Table 40. Americas Plasma Derived Medicine Sales by Application (2019-2024) & (K Bottles)
Table 41. APAC Plasma Derived Medicine Sales by Region (2019-2024) & (K Bottles)
Table 42. APAC Plasma Derived Medicine Sales Market Share by Region (2019-2024)
Table 43. APAC Plasma Derived Medicine Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Plasma Derived Medicine Revenue Market Share by Region (2019-2024)
Table 45. APAC Plasma Derived Medicine Sales by Type (2019-2024) & (K Bottles)
Table 46. APAC Plasma Derived Medicine Sales by Application (2019-2024) & (K Bottles)
Table 47. Europe Plasma Derived Medicine Sales by Country (2019-2024) & (K Bottles)
Table 48. Europe Plasma Derived Medicine Sales Market Share by Country (2019-2024)
Table 49. Europe Plasma Derived Medicine Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Plasma Derived Medicine Revenue Market Share by Country (2019-2024)
Table 51. Europe Plasma Derived Medicine Sales by Type (2019-2024) & (K Bottles)
Table 52. Europe Plasma Derived Medicine Sales by Application (2019-2024) & (K Bottles)
Table 53. Middle East & Africa Plasma Derived Medicine Sales by Country (2019-2024) & (K Bottles)
Table 54. Middle East & Africa Plasma Derived Medicine Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Plasma Derived Medicine Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Plasma Derived Medicine Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Plasma Derived Medicine Sales by Type (2019-2024) & (K Bottles)
Table 58. Middle East & Africa Plasma Derived Medicine Sales by Application (2019-2024) & (K Bottles)
Table 59. Key Market Drivers & Growth Opportunities of Plasma Derived Medicine
Table 60. Key Market Challenges & Risks of Plasma Derived Medicine
Table 61. Key Industry Trends of Plasma Derived Medicine
Table 62. Plasma Derived Medicine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Plasma Derived Medicine Distributors List
Table 65. Plasma Derived Medicine Customer List
Table 66. Global Plasma Derived Medicine Sales Forecast by Region (2025-2030) & (K Bottles)
Table 67. Global Plasma Derived Medicine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Plasma Derived Medicine Sales Forecast by Country (2025-2030) & (K Bottles)
Table 69. Americas Plasma Derived Medicine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Plasma Derived Medicine Sales Forecast by Region (2025-2030) & (K Bottles)
Table 71. APAC Plasma Derived Medicine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Plasma Derived Medicine Sales Forecast by Country (2025-2030) & (K Bottles)
Table 73. Europe Plasma Derived Medicine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Plasma Derived Medicine Sales Forecast by Country (2025-2030) & (K Bottles)
Table 75. Middle East & Africa Plasma Derived Medicine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Plasma Derived Medicine Sales Forecast by Type (2025-2030) & (K Bottles)
Table 77. Global Plasma Derived Medicine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Plasma Derived Medicine Sales Forecast by Application (2025-2030) & (K Bottles)
Table 79. Global Plasma Derived Medicine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Takeda Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 81. Takeda Plasma Derived Medicine Product Portfolios and Specifications
Table 82. Takeda Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 83. Takeda Main Business
Table 84. Takeda Latest Developments
Table 85. CSL Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 86. CSL Plasma Derived Medicine Product Portfolios and Specifications
Table 87. CSL Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 88. CSL Main Business
Table 89. CSL Latest Developments
Table 90. Grifols Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 91. Grifols Plasma Derived Medicine Product Portfolios and Specifications
Table 92. Grifols Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 93. Grifols Main Business
Table 94. Grifols Latest Developments
Table 95. Octapharma Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 96. Octapharma Plasma Derived Medicine Product Portfolios and Specifications
Table 97. Octapharma Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 98. Octapharma Main Business
Table 99. Octapharma Latest Developments
Table 100. Kedrion Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 101. Kedrion Plasma Derived Medicine Product Portfolios and Specifications
Table 102. Kedrion Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 103. Kedrion Main Business
Table 104. Kedrion Latest Developments
Table 105. LFB Group Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 106. LFB Group Plasma Derived Medicine Product Portfolios and Specifications
Table 107. LFB Group Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 108. LFB Group Main Business
Table 109. LFB Group Latest Developments
Table 110. Biotest Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 111. Biotest Plasma Derived Medicine Product Portfolios and Specifications
Table 112. Biotest Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 113. Biotest Main Business
Table 114. Biotest Latest Developments
Table 115. BPL Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 116. BPL Plasma Derived Medicine Product Portfolios and Specifications
Table 117. BPL Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 118. BPL Main Business
Table 119. BPL Latest Developments
Table 120. Shanghai RAAS Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 121. Shanghai RAAS Plasma Derived Medicine Product Portfolios and Specifications
Table 122. Shanghai RAAS Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 123. Shanghai RAAS Main Business
Table 124. Shanghai RAAS Latest Developments
Table 125. China Biologic Products Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 126. China Biologic Products Plasma Derived Medicine Product Portfolios and Specifications
Table 127. China Biologic Products Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 128. China Biologic Products Main Business
Table 129. China Biologic Products Latest Developments
Table 130. Hualan Biological Engineering Inc. Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Biological Engineering Inc. Plasma Derived Medicine Product Portfolios and Specifications
Table 132. Hualan Biological Engineering Inc. Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 133. Hualan Biological Engineering Inc. Main Business
Table 134. Hualan Biological Engineering Inc. Latest Developments
Table 135. Beijing Tiantan Biological Products Corp Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 136. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Portfolios and Specifications
Table 137. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 138. Beijing Tiantan Biological Products Corp Main Business
Table 139. Beijing Tiantan Biological Products Corp Latest Developments
Table 140. Pacific Shuanglin Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 141. Pacific Shuanglin Plasma Derived Medicine Product Portfolios and Specifications
Table 142. Pacific Shuanglin Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 143. Pacific Shuanglin Main Business
Table 144. Pacific Shuanglin Latest Developments
Table 145. Boya Bio-Pharmaceutical Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 146. Boya Bio-Pharmaceutical Plasma Derived Medicine Product Portfolios and Specifications
Table 147. Boya Bio-Pharmaceutical Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 148. Boya Bio-Pharmaceutical Main Business
Table 149. Boya Bio-Pharmaceutical Latest Developments
Table 150. Paisi Feike Biology Pharmacy Co., Ltd. Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 151. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Portfolios and Specifications
Table 152. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 153. Paisi Feike Biology Pharmacy Co., Ltd. Main Business
Table 154. Paisi Feike Biology Pharmacy Co., Ltd. Latest Developments
Table 155. Xinjiang Deyuan Bioengineering Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 156. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Portfolios and Specifications
Table 157. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 158. Xinjiang Deyuan Bioengineering Main Business
Table 159. Xinjiang Deyuan Bioengineering Latest Developments
Table 160. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 161. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Portfolios and Specifications
Table 162. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 163. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Main Business
Table 164. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Latest Developments
Table 165. Shenzhen Weiguang Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 166. Shenzhen Weiguang Plasma Derived Medicine Product Portfolios and Specifications
Table 167. Shenzhen Weiguang Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 168. Shenzhen Weiguang Main Business
Table 169. Shenzhen Weiguang Latest Developments
Table 170. Shanxi Kangbao Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 171. Shanxi Kangbao Plasma Derived Medicine Product Portfolios and Specifications
Table 172. Shanxi Kangbao Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 173. Shanxi Kangbao Main Business
Table 174. Shanxi Kangbao Latest Developments
Table 175. Nanyue Biopharming Corporation Ltd Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 176. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Portfolios and Specifications
Table 177. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 178. Nanyue Biopharming Corporation Ltd Main Business
Table 179. Nanyue Biopharming Corporation Ltd Latest Developments
Table 1. Plasma Derived Medicine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Plasma Derived Medicine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Albumin
Table 4. Major Players of Immune Globulin
Table 5. Major Players of Coagulation Factor
Table 6. Major Players of Others
Table 7. Global Plasma Derived Medicine Sales by Type (2019-2024) & (K Bottles)
Table 8. Global Plasma Derived Medicine Sales Market Share by Type (2019-2024)
Table 9. Global Plasma Derived Medicine Revenue by Type (2019-2024) & ($ million)
Table 10. Global Plasma Derived Medicine Revenue Market Share by Type (2019-2024)
Table 11. Global Plasma Derived Medicine Sale Price by Type (2019-2024) & (USD/Bottle)
Table 12. Global Plasma Derived Medicine Sales by Application (2019-2024) & (K Bottles)
Table 13. Global Plasma Derived Medicine Sales Market Share by Application (2019-2024)
Table 14. Global Plasma Derived Medicine Revenue by Application (2019-2024)
Table 15. Global Plasma Derived Medicine Revenue Market Share by Application (2019-2024)
Table 16. Global Plasma Derived Medicine Sale Price by Application (2019-2024) & (USD/Bottle)
Table 17. Global Plasma Derived Medicine Sales by Company (2019-2024) & (K Bottles)
Table 18. Global Plasma Derived Medicine Sales Market Share by Company (2019-2024)
Table 19. Global Plasma Derived Medicine Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Plasma Derived Medicine Revenue Market Share by Company (2019-2024)
Table 21. Global Plasma Derived Medicine Sale Price by Company (2019-2024) & (USD/Bottle)
Table 22. Key Manufacturers Plasma Derived Medicine Producing Area Distribution and Sales Area
Table 23. Players Plasma Derived Medicine Products Offered
Table 24. Plasma Derived Medicine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Plasma Derived Medicine Sales by Geographic Region (2019-2024) & (K Bottles)
Table 28. Global Plasma Derived Medicine Sales Market Share Geographic Region (2019-2024)
Table 29. Global Plasma Derived Medicine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Plasma Derived Medicine Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Plasma Derived Medicine Sales by Country/Region (2019-2024) & (K Bottles)
Table 32. Global Plasma Derived Medicine Sales Market Share by Country/Region (2019-2024)
Table 33. Global Plasma Derived Medicine Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Plasma Derived Medicine Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Plasma Derived Medicine Sales by Country (2019-2024) & (K Bottles)
Table 36. Americas Plasma Derived Medicine Sales Market Share by Country (2019-2024)
Table 37. Americas Plasma Derived Medicine Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Plasma Derived Medicine Revenue Market Share by Country (2019-2024)
Table 39. Americas Plasma Derived Medicine Sales by Type (2019-2024) & (K Bottles)
Table 40. Americas Plasma Derived Medicine Sales by Application (2019-2024) & (K Bottles)
Table 41. APAC Plasma Derived Medicine Sales by Region (2019-2024) & (K Bottles)
Table 42. APAC Plasma Derived Medicine Sales Market Share by Region (2019-2024)
Table 43. APAC Plasma Derived Medicine Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Plasma Derived Medicine Revenue Market Share by Region (2019-2024)
Table 45. APAC Plasma Derived Medicine Sales by Type (2019-2024) & (K Bottles)
Table 46. APAC Plasma Derived Medicine Sales by Application (2019-2024) & (K Bottles)
Table 47. Europe Plasma Derived Medicine Sales by Country (2019-2024) & (K Bottles)
Table 48. Europe Plasma Derived Medicine Sales Market Share by Country (2019-2024)
Table 49. Europe Plasma Derived Medicine Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Plasma Derived Medicine Revenue Market Share by Country (2019-2024)
Table 51. Europe Plasma Derived Medicine Sales by Type (2019-2024) & (K Bottles)
Table 52. Europe Plasma Derived Medicine Sales by Application (2019-2024) & (K Bottles)
Table 53. Middle East & Africa Plasma Derived Medicine Sales by Country (2019-2024) & (K Bottles)
Table 54. Middle East & Africa Plasma Derived Medicine Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Plasma Derived Medicine Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Plasma Derived Medicine Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Plasma Derived Medicine Sales by Type (2019-2024) & (K Bottles)
Table 58. Middle East & Africa Plasma Derived Medicine Sales by Application (2019-2024) & (K Bottles)
Table 59. Key Market Drivers & Growth Opportunities of Plasma Derived Medicine
Table 60. Key Market Challenges & Risks of Plasma Derived Medicine
Table 61. Key Industry Trends of Plasma Derived Medicine
Table 62. Plasma Derived Medicine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Plasma Derived Medicine Distributors List
Table 65. Plasma Derived Medicine Customer List
Table 66. Global Plasma Derived Medicine Sales Forecast by Region (2025-2030) & (K Bottles)
Table 67. Global Plasma Derived Medicine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Plasma Derived Medicine Sales Forecast by Country (2025-2030) & (K Bottles)
Table 69. Americas Plasma Derived Medicine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Plasma Derived Medicine Sales Forecast by Region (2025-2030) & (K Bottles)
Table 71. APAC Plasma Derived Medicine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Plasma Derived Medicine Sales Forecast by Country (2025-2030) & (K Bottles)
Table 73. Europe Plasma Derived Medicine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Plasma Derived Medicine Sales Forecast by Country (2025-2030) & (K Bottles)
Table 75. Middle East & Africa Plasma Derived Medicine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Plasma Derived Medicine Sales Forecast by Type (2025-2030) & (K Bottles)
Table 77. Global Plasma Derived Medicine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Plasma Derived Medicine Sales Forecast by Application (2025-2030) & (K Bottles)
Table 79. Global Plasma Derived Medicine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Takeda Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 81. Takeda Plasma Derived Medicine Product Portfolios and Specifications
Table 82. Takeda Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 83. Takeda Main Business
Table 84. Takeda Latest Developments
Table 85. CSL Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 86. CSL Plasma Derived Medicine Product Portfolios and Specifications
Table 87. CSL Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 88. CSL Main Business
Table 89. CSL Latest Developments
Table 90. Grifols Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 91. Grifols Plasma Derived Medicine Product Portfolios and Specifications
Table 92. Grifols Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 93. Grifols Main Business
Table 94. Grifols Latest Developments
Table 95. Octapharma Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 96. Octapharma Plasma Derived Medicine Product Portfolios and Specifications
Table 97. Octapharma Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 98. Octapharma Main Business
Table 99. Octapharma Latest Developments
Table 100. Kedrion Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 101. Kedrion Plasma Derived Medicine Product Portfolios and Specifications
Table 102. Kedrion Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 103. Kedrion Main Business
Table 104. Kedrion Latest Developments
Table 105. LFB Group Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 106. LFB Group Plasma Derived Medicine Product Portfolios and Specifications
Table 107. LFB Group Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 108. LFB Group Main Business
Table 109. LFB Group Latest Developments
Table 110. Biotest Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 111. Biotest Plasma Derived Medicine Product Portfolios and Specifications
Table 112. Biotest Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 113. Biotest Main Business
Table 114. Biotest Latest Developments
Table 115. BPL Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 116. BPL Plasma Derived Medicine Product Portfolios and Specifications
Table 117. BPL Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 118. BPL Main Business
Table 119. BPL Latest Developments
Table 120. Shanghai RAAS Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 121. Shanghai RAAS Plasma Derived Medicine Product Portfolios and Specifications
Table 122. Shanghai RAAS Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 123. Shanghai RAAS Main Business
Table 124. Shanghai RAAS Latest Developments
Table 125. China Biologic Products Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 126. China Biologic Products Plasma Derived Medicine Product Portfolios and Specifications
Table 127. China Biologic Products Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 128. China Biologic Products Main Business
Table 129. China Biologic Products Latest Developments
Table 130. Hualan Biological Engineering Inc. Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Biological Engineering Inc. Plasma Derived Medicine Product Portfolios and Specifications
Table 132. Hualan Biological Engineering Inc. Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 133. Hualan Biological Engineering Inc. Main Business
Table 134. Hualan Biological Engineering Inc. Latest Developments
Table 135. Beijing Tiantan Biological Products Corp Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 136. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Portfolios and Specifications
Table 137. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 138. Beijing Tiantan Biological Products Corp Main Business
Table 139. Beijing Tiantan Biological Products Corp Latest Developments
Table 140. Pacific Shuanglin Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 141. Pacific Shuanglin Plasma Derived Medicine Product Portfolios and Specifications
Table 142. Pacific Shuanglin Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 143. Pacific Shuanglin Main Business
Table 144. Pacific Shuanglin Latest Developments
Table 145. Boya Bio-Pharmaceutical Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 146. Boya Bio-Pharmaceutical Plasma Derived Medicine Product Portfolios and Specifications
Table 147. Boya Bio-Pharmaceutical Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 148. Boya Bio-Pharmaceutical Main Business
Table 149. Boya Bio-Pharmaceutical Latest Developments
Table 150. Paisi Feike Biology Pharmacy Co., Ltd. Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 151. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Portfolios and Specifications
Table 152. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 153. Paisi Feike Biology Pharmacy Co., Ltd. Main Business
Table 154. Paisi Feike Biology Pharmacy Co., Ltd. Latest Developments
Table 155. Xinjiang Deyuan Bioengineering Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 156. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Portfolios and Specifications
Table 157. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 158. Xinjiang Deyuan Bioengineering Main Business
Table 159. Xinjiang Deyuan Bioengineering Latest Developments
Table 160. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 161. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Portfolios and Specifications
Table 162. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 163. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Main Business
Table 164. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Latest Developments
Table 165. Shenzhen Weiguang Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 166. Shenzhen Weiguang Plasma Derived Medicine Product Portfolios and Specifications
Table 167. Shenzhen Weiguang Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 168. Shenzhen Weiguang Main Business
Table 169. Shenzhen Weiguang Latest Developments
Table 170. Shanxi Kangbao Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 171. Shanxi Kangbao Plasma Derived Medicine Product Portfolios and Specifications
Table 172. Shanxi Kangbao Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 173. Shanxi Kangbao Main Business
Table 174. Shanxi Kangbao Latest Developments
Table 175. Nanyue Biopharming Corporation Ltd Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors
Table 176. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Portfolios and Specifications
Table 177. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 178. Nanyue Biopharming Corporation Ltd Main Business
Table 179. Nanyue Biopharming Corporation Ltd Latest Developments
LIST OF FIGURES
Figure 1. Picture of Plasma Derived Medicine
Figure 2. Plasma Derived Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma Derived Medicine Sales Growth Rate 2019-2030 (K Bottles)
Figure 7. Global Plasma Derived Medicine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Plasma Derived Medicine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Albumin
Figure 10. Product Picture of Immune Globulin
Figure 11. Product Picture of Coagulation Factor
Figure 12. Product Picture of Others
Figure 13. Global Plasma Derived Medicine Sales Market Share by Type in 2023
Figure 14. Global Plasma Derived Medicine Revenue Market Share by Type (2019-2024)
Figure 15. Plasma Derived Medicine Consumed in Bleeding Wound
Figure 16. Global Plasma Derived Medicine Market: Bleeding Wound (2019-2024) & (K Bottles)
Figure 17. Plasma Derived Medicine Consumed in Immunodeficiency
Figure 18. Global Plasma Derived Medicine Market: Immunodeficiency (2019-2024) & (K Bottles)
Figure 19. Plasma Derived Medicine Consumed in HBV
Figure 20. Global Plasma Derived Medicine Market: HBV (2019-2024) & (K Bottles)
Figure 21. Plasma Derived Medicine Consumed in Tetanus
Figure 22. Global Plasma Derived Medicine Market: Tetanus (2019-2024) & (K Bottles)
Figure 23. Plasma Derived Medicine Consumed in Rabies
Figure 24. Global Plasma Derived Medicine Market: Rabies (2019-2024) & (K Bottles)
Figure 25. Plasma Derived Medicine Consumed in Hemophilia
Figure 26. Global Plasma Derived Medicine Market: Hemophilia (2019-2024) & (K Bottles)
Figure 27. Plasma Derived Medicine Consumed in Others
Figure 28. Global Plasma Derived Medicine Market: Others (2019-2024) & (K Bottles)
Figure 29. Global Plasma Derived Medicine Sales Market Share by Application (2023)
Figure 30. Global Plasma Derived Medicine Revenue Market Share by Application in 2023
Figure 31. Plasma Derived Medicine Sales Market by Company in 2023 (K Bottles)
Figure 32. Global Plasma Derived Medicine Sales Market Share by Company in 2023
Figure 33. Plasma Derived Medicine Revenue Market by Company in 2023 ($ Million)
Figure 34. Global Plasma Derived Medicine Revenue Market Share by Company in 2023
Figure 35. Global Plasma Derived Medicine Sales Market Share by Geographic Region (2019-2024)
Figure 36. Global Plasma Derived Medicine Revenue Market Share by Geographic Region in 2023
Figure 37. Americas Plasma Derived Medicine Sales 2019-2024 (K Bottles)
Figure 38. Americas Plasma Derived Medicine Revenue 2019-2024 ($ Millions)
Figure 39. APAC Plasma Derived Medicine Sales 2019-2024 (K Bottles)
Figure 40. APAC Plasma Derived Medicine Revenue 2019-2024 ($ Millions)
Figure 41. Europe Plasma Derived Medicine Sales 2019-2024 (K Bottles)
Figure 42. Europe Plasma Derived Medicine Revenue 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Plasma Derived Medicine Sales 2019-2024 (K Bottles)
Figure 44. Middle East & Africa Plasma Derived Medicine Revenue 2019-2024 ($ Millions)
Figure 45. Americas Plasma Derived Medicine Sales Market Share by Country in 2023
Figure 46. Americas Plasma Derived Medicine Revenue Market Share by Country in 2023
Figure 47. Americas Plasma Derived Medicine Sales Market Share by Type (2019-2024)
Figure 48. Americas Plasma Derived Medicine Sales Market Share by Application (2019-2024)
Figure 49. United States Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Canada Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 51. Mexico Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Brazil Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 53. APAC Plasma Derived Medicine Sales Market Share by Region in 2023
Figure 54. APAC Plasma Derived Medicine Revenue Market Share by Regions in 2023
Figure 55. APAC Plasma Derived Medicine Sales Market Share by Type (2019-2024)
Figure 56. APAC Plasma Derived Medicine Sales Market Share by Application (2019-2024)
Figure 57. China Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 58. Japan Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 59. South Korea Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Southeast Asia Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 61. India Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Australia Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 63. China Taiwan Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 64. Europe Plasma Derived Medicine Sales Market Share by Country in 2023
Figure 65. Europe Plasma Derived Medicine Revenue Market Share by Country in 2023
Figure 66. Europe Plasma Derived Medicine Sales Market Share by Type (2019-2024)
Figure 67. Europe Plasma Derived Medicine Sales Market Share by Application (2019-2024)
Figure 68. Germany Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 69. France Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 70. UK Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 71. Italy Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Russia Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 73. Middle East & Africa Plasma Derived Medicine Sales Market Share by Country in 2023
Figure 74. Middle East & Africa Plasma Derived Medicine Revenue Market Share by Country in 2023
Figure 75. Middle East & Africa Plasma Derived Medicine Sales Market Share by Type (2019-2024)
Figure 76. Middle East & Africa Plasma Derived Medicine Sales Market Share by Application (2019-2024)
Figure 77. Egypt Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 78. South Africa Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 79. Israel Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 80. Turkey Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 81. GCC Country Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 82. Manufacturing Cost Structure Analysis of Plasma Derived Medicine in 2023
Figure 83. Manufacturing Process Analysis of Plasma Derived Medicine
Figure 84. Industry Chain Structure of Plasma Derived Medicine
Figure 85. Channels of Distribution
Figure 86. Global Plasma Derived Medicine Sales Market Forecast by Region (2025-2030)
Figure 87. Global Plasma Derived Medicine Revenue Market Share Forecast by Region (2025-2030)
Figure 88. Global Plasma Derived Medicine Sales Market Share Forecast by Type (2025-2030)
Figure 89. Global Plasma Derived Medicine Revenue Market Share Forecast by Type (2025-2030)
Figure 90. Global Plasma Derived Medicine Sales Market Share Forecast by Application (2025-2030)
Figure 91. Global Plasma Derived Medicine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Plasma Derived Medicine
Figure 2. Plasma Derived Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma Derived Medicine Sales Growth Rate 2019-2030 (K Bottles)
Figure 7. Global Plasma Derived Medicine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Plasma Derived Medicine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Albumin
Figure 10. Product Picture of Immune Globulin
Figure 11. Product Picture of Coagulation Factor
Figure 12. Product Picture of Others
Figure 13. Global Plasma Derived Medicine Sales Market Share by Type in 2023
Figure 14. Global Plasma Derived Medicine Revenue Market Share by Type (2019-2024)
Figure 15. Plasma Derived Medicine Consumed in Bleeding Wound
Figure 16. Global Plasma Derived Medicine Market: Bleeding Wound (2019-2024) & (K Bottles)
Figure 17. Plasma Derived Medicine Consumed in Immunodeficiency
Figure 18. Global Plasma Derived Medicine Market: Immunodeficiency (2019-2024) & (K Bottles)
Figure 19. Plasma Derived Medicine Consumed in HBV
Figure 20. Global Plasma Derived Medicine Market: HBV (2019-2024) & (K Bottles)
Figure 21. Plasma Derived Medicine Consumed in Tetanus
Figure 22. Global Plasma Derived Medicine Market: Tetanus (2019-2024) & (K Bottles)
Figure 23. Plasma Derived Medicine Consumed in Rabies
Figure 24. Global Plasma Derived Medicine Market: Rabies (2019-2024) & (K Bottles)
Figure 25. Plasma Derived Medicine Consumed in Hemophilia
Figure 26. Global Plasma Derived Medicine Market: Hemophilia (2019-2024) & (K Bottles)
Figure 27. Plasma Derived Medicine Consumed in Others
Figure 28. Global Plasma Derived Medicine Market: Others (2019-2024) & (K Bottles)
Figure 29. Global Plasma Derived Medicine Sales Market Share by Application (2023)
Figure 30. Global Plasma Derived Medicine Revenue Market Share by Application in 2023
Figure 31. Plasma Derived Medicine Sales Market by Company in 2023 (K Bottles)
Figure 32. Global Plasma Derived Medicine Sales Market Share by Company in 2023
Figure 33. Plasma Derived Medicine Revenue Market by Company in 2023 ($ Million)
Figure 34. Global Plasma Derived Medicine Revenue Market Share by Company in 2023
Figure 35. Global Plasma Derived Medicine Sales Market Share by Geographic Region (2019-2024)
Figure 36. Global Plasma Derived Medicine Revenue Market Share by Geographic Region in 2023
Figure 37. Americas Plasma Derived Medicine Sales 2019-2024 (K Bottles)
Figure 38. Americas Plasma Derived Medicine Revenue 2019-2024 ($ Millions)
Figure 39. APAC Plasma Derived Medicine Sales 2019-2024 (K Bottles)
Figure 40. APAC Plasma Derived Medicine Revenue 2019-2024 ($ Millions)
Figure 41. Europe Plasma Derived Medicine Sales 2019-2024 (K Bottles)
Figure 42. Europe Plasma Derived Medicine Revenue 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Plasma Derived Medicine Sales 2019-2024 (K Bottles)
Figure 44. Middle East & Africa Plasma Derived Medicine Revenue 2019-2024 ($ Millions)
Figure 45. Americas Plasma Derived Medicine Sales Market Share by Country in 2023
Figure 46. Americas Plasma Derived Medicine Revenue Market Share by Country in 2023
Figure 47. Americas Plasma Derived Medicine Sales Market Share by Type (2019-2024)
Figure 48. Americas Plasma Derived Medicine Sales Market Share by Application (2019-2024)
Figure 49. United States Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Canada Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 51. Mexico Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Brazil Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 53. APAC Plasma Derived Medicine Sales Market Share by Region in 2023
Figure 54. APAC Plasma Derived Medicine Revenue Market Share by Regions in 2023
Figure 55. APAC Plasma Derived Medicine Sales Market Share by Type (2019-2024)
Figure 56. APAC Plasma Derived Medicine Sales Market Share by Application (2019-2024)
Figure 57. China Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 58. Japan Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 59. South Korea Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Southeast Asia Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 61. India Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Australia Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 63. China Taiwan Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 64. Europe Plasma Derived Medicine Sales Market Share by Country in 2023
Figure 65. Europe Plasma Derived Medicine Revenue Market Share by Country in 2023
Figure 66. Europe Plasma Derived Medicine Sales Market Share by Type (2019-2024)
Figure 67. Europe Plasma Derived Medicine Sales Market Share by Application (2019-2024)
Figure 68. Germany Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 69. France Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 70. UK Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 71. Italy Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Russia Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 73. Middle East & Africa Plasma Derived Medicine Sales Market Share by Country in 2023
Figure 74. Middle East & Africa Plasma Derived Medicine Revenue Market Share by Country in 2023
Figure 75. Middle East & Africa Plasma Derived Medicine Sales Market Share by Type (2019-2024)
Figure 76. Middle East & Africa Plasma Derived Medicine Sales Market Share by Application (2019-2024)
Figure 77. Egypt Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 78. South Africa Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 79. Israel Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 80. Turkey Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 81. GCC Country Plasma Derived Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 82. Manufacturing Cost Structure Analysis of Plasma Derived Medicine in 2023
Figure 83. Manufacturing Process Analysis of Plasma Derived Medicine
Figure 84. Industry Chain Structure of Plasma Derived Medicine
Figure 85. Channels of Distribution
Figure 86. Global Plasma Derived Medicine Sales Market Forecast by Region (2025-2030)
Figure 87. Global Plasma Derived Medicine Revenue Market Share Forecast by Region (2025-2030)
Figure 88. Global Plasma Derived Medicine Sales Market Share Forecast by Type (2025-2030)
Figure 89. Global Plasma Derived Medicine Revenue Market Share Forecast by Type (2025-2030)
Figure 90. Global Plasma Derived Medicine Sales Market Share Forecast by Application (2025-2030)
Figure 91. Global Plasma Derived Medicine Revenue Market Share Forecast by Application (2025-2030)
